SEVERE ASTHMA

This study looks at the long-term safety and effectiveness of a drug called verekitug for adults with severe asthma. It includes 396 people who already finished the VALIANT trial. The goal is to see if the drug is safe over time and helps control asthma attacks.

This study tests if tezepelumab, a monthly injection, can help people with severe asthma safely reduce their daily maintenance inhaler (SYMBICORT) while still keeping their asthma under control. About 326 adolescents and adults will be followed for up to 72 weeks. The goal is to …

This study looks at how well tezepelumab works for people aged 12 and older with severe asthma in Russia. Over 52 weeks, researchers track changes in asthma control and symptoms using patient questionnaires. The goal is to understand the real-world benefits of this treatment for …

This study planned to compare levels of certain immune cells (ILC2) in the lungs of children with severe asthma versus children without asthma. The goal was to see if these cells are higher in asthmatic children and if they relate to other markers of airway inflammation. However,…

This study uses artificial intelligence and natural language processing to automatically identify people with moderate to severe asthma from electronic health records. Researchers will compare the AI's findings to diagnoses made by doctors to see how accurate the technology is. T…

This study aims to identify proteins in blood, saliva, and sputum that can help doctors predict organ damage and how well patients with EGPA (a rare inflammatory disease) or severe asthma respond to the drug mepolizumab. Researchers will analyze samples from 90 participants befor…

This study follows 362 children with severe asthma to find out what makes their asthma worse and how it changes as they grow up. Researchers will compare them with children who have milder asthma to identify key risk factors. The goal is to better understand severe asthma from ch…